Vivos Therapeutics (VVOS) News Today $5.74 -0.21 (-3.53%) Closing price 01/17/2025 04:00 PM EasternExtended Trading$5.70 -0.04 (-0.61%) As of 09:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Head-To-Head Analysis: Sensus Healthcare (NASDAQ:SRTS) & Vivos Therapeutics (NASDAQ:VVOS)January 19 at 2:21 AM | americanbankingnews.comVivos to sell 709,220 shares at $4.935 in registered direct offeringDecember 23, 2024 | markets.businessinsider.comVivos Therapeutics announces funding boostDecember 23, 2024 | proactiveinvestors.comVivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesDecember 23, 2024 | globenewswire.comVivos Therapeutics price target lowered to $6 from $8.25 at Alliance Global PartnersNovember 19, 2024 | markets.businessinsider.comVivos Therapeutics Inc (VVOS) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...November 16, 2024 | finance.yahoo.comVivos Therapeutics Reports Revenue Growth and Strategic MilestonesNovember 16, 2024 | markets.businessinsider.comVivos Therapeutics, Inc. (NASDAQ:VVOS) Q3 2024 Earnings Call TranscriptNovember 16, 2024 | msn.comVivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational UpdateNovember 15, 2024 | markets.businessinsider.comVivos Therapeutics, Inc. (VVOS) Q3 2024 Earnings Call TranscriptNovember 15, 2024 | seekingalpha.comVivos Therapeutics eyes positive cash flow as it continues cost-reduction success in Q3November 14, 2024 | proactiveinvestors.comVivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference CallNovember 13, 2024 | globenewswire.comInvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces AMA Issues CPT Codes, Coverage for Vivos CARE Oral Medical DevicesOctober 9, 2024 | msn.comVivos Therapeutics wins approval for streamlined insurance reimbursement for sleep apnea treatmentOctober 8, 2024 | proactiveinvestors.comVivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical AssociationOctober 8, 2024 | globenewswire.comTinyGemsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces $4.3M Registered Direct OfferingSeptember 20, 2024 | msn.comVivos Therapeutics Shares Drop 27% After Pricing of Common Stock OfferingSeptember 19, 2024 | marketwatch.comVivos Therapeutics Offers Of 1.363 Mln Shares At $3.15/share, Pre-Market Stock DownSeptember 19, 2024 | markets.businessinsider.comWhy Vivos Therapeutics (VVOS) Stock Is Down 25% TodaySeptember 19, 2024 | msn.comVivos Therapeutics raises $4.3 from institutional investorsSeptember 19, 2024 | proactiveinvestors.comVivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq RulesSeptember 19, 2024 | finance.yahoo.comVivos Therapeutics, Inc: Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and SnoringSeptember 18, 2024 | finanznachrichten.deVivos Therapeutics Shares Rally on FDA Clearance for Pediatric Sleep Apnea TreatmentSeptember 18, 2024 | marketwatch.comVivos Therapeutics Gets FDA 510(k) Clearance To Treat Pediatric Sleep Apnea, Snoring; Stock UpSeptember 18, 2024 | markets.businessinsider.comVivos Therapeutics Says It Is Poised To Disrupt Pediatric Sleep Apnea Market, Secures FDA Approval For DNA Appliance To Treat Snoring In ChildrenSeptember 18, 2024 | finance.yahoo.comVivos Therapeutics' oral device approved by FDA for pediatric sleep apnea treatmentSeptember 18, 2024 | proactiveinvestors.comVivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and SnoringSeptember 18, 2024 | globenewswire.com3 Trending Biotech Penny StocksAugust 22, 2024 | 247wallst.comVVOS Stock Earnings: Vivos Therapeutics Beats EPS, Beats Revenue for Q2 2024August 15, 2024 | markets.businessinsider.comInvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Report on Q2 2024 Financial Results, Operational UpdateAugust 15, 2024 | msn.comVivos Therapeutics boosts Q2 revenue, cuts operating losses amid new strategic partnershipsAugust 14, 2024 | proactiveinvestors.comVivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational UpdateAugust 14, 2024 | globenewswire.comVivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference CallAugust 14, 2024 | stockhouse.comInvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Plans Release of Q2 2024 Financial Results, Conference CallAugust 14, 2024 | msn.comVivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference CallAugust 14, 2024 | globenewswire.comVivos Therapeutics reports positive results from pilot of provider-based modelJune 27, 2024 | proactiveinvestors.comVivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution ModelJune 27, 2024 | globenewswire.comVivos Therapeutics announces strategic alliance and $7.5M investmentJune 12, 2024 | proactiveinvestors.comVivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution AllianceJune 12, 2024 | globenewswire.comVivos Therapeutics, Inc. (NASDAQ:VVOS) Q1 2024 Earnings Call TranscriptMay 19, 2024 | msn.comVivos Therapeutics GAAP EPS of -$1.63, revenue of $3.4MMay 15, 2024 | msn.comVivos Therapeutics Inc (VVOS) Q1 2024 Earnings Call Transcript Highlights: Navigating ...May 15, 2024 | finance.yahoo.comVVOS Stock Earnings: Vivos Therapeutics Reported Results for Q1 2024May 14, 2024 | investorplace.comVivos Therapeutics reports first quarter cost savings, launches revenue-generating initiativeMay 14, 2024 | proactiveinvestors.comVivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational UpdateMay 14, 2024 | globenewswire.comVivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference CallMay 14, 2024 | globenewswire.comVivos Therapeutics expects increased adoption of oral medical devices following Medicare reimbursement approvalApril 11, 2024 | proactiveinvestors.comVivos Therapeutics receives approval for Medicare reimbursement for flagship Oral Medical DevicesApril 9, 2024 | finance.yahoo.comVivos Gets Approval To Facilitate Full Medicare Reimbursement For CARE Sleep Apnea Oral DevicesApril 9, 2024 | markets.businessinsider.comWhat's Going On With Vivos Therapeutics Stock?April 9, 2024 | msn.com Get Vivos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VVOS and its competitors with MarketBeat's FREE daily newsletter. Email Address VVOS Media Mentions By Week VVOS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VVOS News Sentiment▼0.500.49▲Average Medical News Sentiment VVOS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VVOS Articles This Week▼11▲VVOS Articles Average Week Get Vivos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VVOS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Sensus Healthcare News Today TELA Bio News Today electroCore News Today LENSAR News Today FONAR News Today Milestone Scientific News Today Monogram Orthopaedics News Today Fractyl Health News Today Edap Tms News Today Neuronetics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VVOS) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vivos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
